Cargando…
Return of results in translational iPS cell research: considerations for donor informed consent
Efforts have emerged internationally to recruit donors with specific disease indications and to derive induced pluripotent cell lines. These disease-specific induced pluripotent stem cell lines have the potential to accelerate translational goals such as drug discovery and testing. One consideration...
Autores principales: | Lomax, Geoffrey P, Shepard, Kelly A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706983/ https://www.ncbi.nlm.nih.gov/pubmed/23336317 http://dx.doi.org/10.1186/scrt154 |
Ejemplares similares
-
Beyond iPS!
Publicado: (2012) -
Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations
por: Karlson, Elizabeth W., et al.
Publicado: (2016) -
The Potential of iPS Cells in Synucleinopathy Research
por: Linta, Leonhard, et al.
Publicado: (2012) -
Aging in iPS cells
por: Miller, Justine, et al.
Publicado: (2014) -
Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
por: Wang, Heuy-Ching, et al.
Publicado: (2014)